What Researchers Did
Researchers conducted a narrative review to explore noninvasive, systemic treatments aimed at preventing or reducing soft tissue injury in head and neck cancer patients undergoing radiation.
What They Found
The review highlighted nine potential modalities, including hyperbaric oxygen therapy, amifostine, and melatonin. However, the authors concluded that none of these nine modalities are currently supported by strong evidence for preventing radiation-associated soft tissue injury.
What This Means for Canadian Patients
For Canadian head and neck cancer patients, this review indicates that there is currently no strong evidence to support the use of these noninvasive systemic treatments for preventing radiation-associated soft tissue injury. Patients should discuss all potential preventative strategies with their care team, understanding the current limitations in evidence for these specific modalities.
Canadian Relevance
The study authors are not identified as Canadian. However, hyperbaric oxygen therapy, one of the modalities reviewed, is a Health Canada-recognized indication for certain conditions, including delayed radiation injury, making the research relevant to Canadian clinical discussions.
Study Limitations
As a narrative review, this study's conclusions are limited by the existing sparse literature and the lack of strong evidence for the prophylactic use of the reviewed modalities.